1 Healthcare Stock Set to Rebound in 2026

Core Viewpoint - UnitedHealth Group is expected to rebound in 2026 despite recent stock struggles, with many of its major issues likely behind it [1] Group 1: Stock Performance - UnitedHealth's stock dropped approximately 35% in 2025 and has continued to decline by over 13% in 2026 [1] - The current stock price is $287.59, with a market cap of $259 billion [2] - The stock is trading at 15.8 times its projected earnings over the next 12 months, indicating more upside potential than downside [5] Group 2: Challenges Faced - The company has faced challenges due to higher costs, negative publicity, and a potentially flat Medicare Advantage payment rate in 2027 [2] - These issues have largely been priced into the stock, suggesting that investors may be underestimating UnitedHealth's market dominance [2] Group 3: Future Outlook - UnitedHealth plans to improve efficiency by scaling back its Medicare Advantage footprint, streamlining operations, and utilizing artificial intelligence to enhance productivity [3] - Revenue is expected to dip slightly from $447.6 billion in 2025 to $439 billion, but earnings are projected to return to growth [4]